A Johansson
05.01.2018
The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT).
Solbeck S, Jensen A, Maschmann C, Stensballe J, Ostrowski S, Johansson A. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT). Scand J Clin Lab Invest 2018; 78:25-30.
05.01.2018The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT).
05.01.2018Scand J Clin Lab Invest 2018; 78:25-30
Solbeck Sacha, Jensen Annette Schophuus, Maschmann Christian, Stensballe Jakob, Ostrowski Sisse Rye, Johansson A
Weiter
17.02.2011
Hydrochlorothiazide compared to candesartan treatment increases adipose tissue gene expression and circulating levels of serum amyloid A in hypertensive patients
Palming J, Jansson P, Renström F, Johansson A, Johansson L, Karlsson C, Lind L, Eriksson J. Hydrochlorothiazide compared to candesartan treatment increases adipose tissue gene expression and circulating levels of serum amyloid A in hypertensive patients. Horm Metab Res 2011; 43:319-24.
17.02.2011Hydrochlorothiazide compared to candesartan treatment increases adipose tissue gene expression and circulating levels of serum amyloid A in hypertensive patients
17.02.2011Horm Metab Res 2011; 43:319-24
Palming J, Jansson P-A, Renström Frida, Johansson A, Johansson L, Karlsson C, Lind L, Eriksson J W
Weiter